NFKB1 and neoplasm: Wang found that APOBEC3B can promote the growth of liver tumor cells through the NF-κB signaling pathway, promote the recruitment of tumor macrophages, and increase the CD8 + T-expressing myeloid-derived suppressor cells and PD1 [62].